does bpc 157 work for herniated disc BPC-157 Peptide Therapy for Pain Management

Comprehensive safety analysis across over 11,000 participants found that serious adverse events were uncommon, and in cardiovascular outcome trials, serious adverse events were actually lower with semaglutide versus placebo

Cagrilintide is for research purposes only and is not intended for human or animal use, diagnosis, treatment, or consumption

Eggermont AMM, Chiarion-Sileni V, Grob J-J, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, et al

In ex vivo studies using isolated blood vessels, BPC-157 induces vasodilation through increased nitric oxide production, with effects blocked by endothelium removal or eNOS inhibition

They found that BPC-157 causes blood vessels to relax and widen, and that this effect depends on the inner lining of the blood vessel and a molecule called nitric oxide